Search

Your selection

None

Filter by content type

Filter by content year

News

Vaxart Initiates Dosing in 10,000-Participant Portion of Phase 2b COVID-19 Trial

May 27, 2025 - … Officer of Vaxart . “Following the lift of the stop work order, we quickly reactivated our clinical trial sites, … Officer of Vaxart . “Following the lift of the stop work order, we quickly reactivated our clinical trial sites, … Officer of Vaxart . “Following the lift of the stop work order, we quickly reactivated our clinical trial sites, …
News

Vaxart Announces Adjournment of Annual Meeting of Stockholders

May 21, 2025 - … votes from its stockholders with respect to all proposals set forth in the Proxy Statement. Proxies previously … votes from its stockholders with respect to all proposals set forth in the Proxy Statement. Proxies previously … votes from its stockholders with respect to all proposals set forth in the Proxy Statement. Proxies previously …
News

Vaxart Publishes Positive, Complete Data from a Phase 2b Challenge Study of its First-Generation Oral Pill Norovirus Vaccine Candidate in Science Translational Medicine

May 14, 2025 - … the quantity and duration of norovirus shedding, and a set of immunogenicity parameters also were quantified. The … the quantity and duration of norovirus shedding, and a set of immunogenicity parameters also were quantified. The … the quantity and duration of norovirus shedding, and a set of immunogenicity parameters also were quantified. The …
News

Vaxart Provides Business Update and Reports First Quarter 2025 Financial Results

May 13, 2025 - … first quarter of 2025. “We are pleased that the stop work order was lifted for the 10,000 participant portion of our … Technology International (“ATI”) that the stop work order for its Phase 2b COVID-19 trial had been lifted and … last modified on February 7, 2025 , prior to the stop work order. The Company may receive funding of up to $460.7 …
News

Vaxart CEO Issues Letter to Stockholders Highlighting Company Progress

May 5, 2025 - … highlight the importance of remaining listed on Nasdaq in order to maintain our progress. We would greatly appreciate … filed Form 8-K , a previously issued government stop work order was lifted on April 24, 2025 , enabling the Company to … we continue to take prudent measures to control costs in order to best position the Company for future success. …
News

Vaxart Provides Business Update and Reports Full Year 2024 Financial Results

March 20, 2025 - … 30-day data. On February 21, 2025 , Vaxart received an order from Advanced Technology International on behalf of the … follow-up for the 400-person cohort. Within 90 days of the order, the stop work order will either be canceled, extended, or work on this … 30-day data. On February 21, 2025 , Vaxart received an order from Advanced Technology International on behalf of the …
News

Vaxart to Present Norovirus Data at IDWeek 2024 Underscoring Commitment to Address Significant Unmet Need

News

Vaxart Announces Positive Results for Its Bivalent Norovirus Vaccine Candidate in Lactating Mothers

News

Vaxart Announces Last Subject Dosed in Phase 1 Trial of Its Norovirus Vaccine Candidate in Lactating Mothers

News

Vaxart Doses First Subject in Phase 1 Trial of Its Norovirus Vaccine Candidate in Lactating Mothers

Scroll to Top